Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Belardinelli; Luiz
Address:
Palo Alto, CA
No. of patents:
12
Patents:












Patent Number Title Of Patent Date Issued
8569260 N-pyrazole A.sub.2A receptor agonists October 29, 2013
The present disclosure provides a process for the preparation of 2-adenosine N-pyrazole compounds exemplified by the structure shown below that are potent and selective agonists for A.sub.2A adenosine receptor, compositions comprising these compounds, and methods for using these comp
8278435 N-pyrazole A2A receptor agonists October 2, 2012
The present disclosure provides a process for the preparation of 2-adenosine N-pyrazole compounds exemplified by the structure shown below that are potent and selective agonists for A.sub.2A adenosine receptor, compositions comprising these compounds, and methods for using these comp
8188099 Method of decreasing hepatotoxic side effects using A.sub.2B adenosine receptor antagonists May 29, 2012
The invention is related to a method of decreasing hepatotoxic side effects using an A2B adenosine receptor antagonist and utility in the treatment of liver damage caused by undergoing hepatotoxic treatment, such as chemotherapy or radiation. The invention also relates to pharmaceuti
8133879 Myocardial perfusion imaging methods and compositions March 13, 2012
The present disclosure provides 2-adenosine N-pyrazole compounds of structural formula shown below that are potent and selective agonists for A.sub.2A adenosine receptor, compositions comprising these compounds, and methods for using these compounds in a variety of applications including
8106029 Use of A.sub.2A adenosine receptor agonists January 31, 2012
Myocardial imaging methods are provided that are accomplished by administering doses of a pharmaceutical composition comprising one or more adenosine A.sub.2A receptor agonists, in particular regadenoson, useful for, among other indications, myocardial imaging and coronary vasodilati
8071566 Methods of coronary imaging December 6, 2011
The present invention provides methods of myocardial perfusion imaging and increasing coronary blood flow of a mammal that are accomplished by administering doses of a compound that is a selective partial A.sub.2A receptor agonist with a short duration of action, in particular regade
7795268 Method of treating hepatic disease using A.sub.2B adenosine receptor antagonists September 14, 2010
The invention is related to methods of treating hepatic fibrosis using A.sub.2B adenosine receptor antagonists and utility in the treatment of liver damage caused by alcohol abuse, surgical intervention, viral hepatitis, the ingestion of hepatotoxic drugs, or other hepatic diseases.
7655637 N-pyrazole A.sub.2A receptor agonists February 2, 2010
2-adenosine N-pyrazole compounds having the following formula: ##STR00001## wherein R.sup.1.dbd.CH.sub.2OH; R.sup.2 is hydrogen; R.sup.3 is selected from the group consisting of CO.sub.2R.sup.20; --CONR.sup.7R.sup.8 ,and aryl wherein the aryl substituent is optionally substituted wi
7655636 Use of A2A adenosine receptor agonists February 2, 2010
The present invention relates to methods for producing coronary vasodilation with little peripheral vasodilation by administering doses of a pharmaceutical composition including regadenoson, named (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminop- urin-2-yl}pyr
7479485 Method of treating arrhythmias January 20, 2009
Methods are provided for treating arrhythmia in a manner that minimizes undesirable side effects, comprising administration of a therapeutically effective minimal dose of an A.sub.1 adenosine receptor agonist with a therapeutically effective minimal dose of a beta blocker, calcium channe
7183264 N-pyrazole A2A receptor agonists February 27, 2007
2-adenosine N-pyrazole compounds having the following formula: ##STR00001## and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart are disclosed.
7144872 N-pyrazole A.sub.2A receptor agonists December 5, 2006
This specification discloses 2-adenosine N-pyrazole compounds having the following formula: ##STR00001## and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.










 
 
  Recently Added Patents
Headset systems and methods
Electrode and method for manufacturing the same
Approaching object detection system
Near-field optical disk having surface plasmon amplification by stimulated emission of radiation
Release layer
Identification wristband
Nickel-cobalt-manganese multi-element lithium ion battery cathode material with dopants and its methods of preparation
  Randomly Featured Patents
Note feeder
Tendon tensioning anchor system having polymeric encapsulation with reduced shrinkage effects
Passive biometric customer identification and tracking system
Cytotoxic agents
Subtilisin 309 variants having decreased adsorption and increased hydrolysis
Detecting a rapid change of a critical physical condition
Arrangement comprising a first semiconductor chip and a second semiconductor chip connected thereto
Electrical continuity tester and tracer
Greenhouse system with co-generation power supply, heating and exhaust gas fertilization
2-piece upright toy vacuum cleaner